What This Trial Looked At
Skin ageing — the appearance of fine lines, increased roughness, and the gradual loss of intradermal collagen — is one of the most visible effects of cumulative oxidative damage over a lifetime. Most cosmetic interventions either replace lost volume from the outside or thermally injure the skin to stimulate repair. A 2014 controlled trial in Photomedicine and Laser Surgery, led by Alexander Wunsch and Karsten Matuschka, took a different approach: could non-thermal red and near-infrared light, delivered consistently over months, actually shift the skin’s underlying collagen structure without injuring it?
The trial enrolled 136 participants randomised into one of three groups: a 611–650 nm red-light source, a broader 570–850 nm polychromatic source, or an untreated control group. The active groups were treated twice weekly for fifteen weeks — 30 sessions in total. Outcomes included blinded evaluation of skin complexion and roughness, patient satisfaction measures, and an objective ultrasound assessment of intradermal collagen density.
What They Found
Both light-treated groups showed significant improvements compared with the untreated controls. Skin complexion and skin feeling improved on blinded clinical assessment. Roughness — measured both visually and by patient self-report — decreased. Patient satisfaction was high in the treated groups.
The most striking objective result came from the ultrasound measurements of intradermal collagen density, which increased significantly in both treated groups compared with controls. Collagen is the structural protein that gives skin its firmness and resilience, and the loss of intradermal collagen is one of the central biological drivers of visible skin ageing. The fact that consistent red-light exposure produced a measurable increase — using a standard ultrasound technique rather than subjective evaluation — gave the trial unusual weight in the photobiomodulation literature.
Interestingly, the broader polychromatic source showed no clear advantage over the red-light-only spectrum. Both produced equivalent benefits — suggesting that the active mechanism centres on red and near-infrared wavelengths rather than the broader visible spectrum.
What This Means in Context
This trial is widely cited as one of the foundational human references for at-home red light therapy in the skin-rejuvenation space. The design was solid — a properly controlled trial with an untreated comparison group, a meaningful sample size, and an objective primary outcome (ultrasound collagen density) rather than purely subjective measures.
What the trial does not address is durability — how long the gains last after the 15-week course ends — or whether the same dose pattern applies to skin conditions beyond ordinary photoageing. Like most photobiomodulation work in skin, the protocol matters: twice-weekly sessions over fifteen weeks is a meaningful commitment, and outcomes in shorter or less frequent regimens may differ.
What It Means for You
If you are considering red light therapy for skin appearance — fine lines, complexion, overall skin feel — this trial provides some of the clearest objective evidence available that consistent use over several months can produce measurable changes in the skin’s underlying collagen, not just the surface. The pattern that gave results was sustained: twice weekly for fifteen weeks. Day-to-day variability matters less than showing up consistently across that kind of timeframe.
Citation: Wunsch, A., & Matuschka, K. (2014). A controlled trial to determine the efficacy of red and near-infrared light treatment in patient satisfaction, reduction of fine lines, wrinkles, skin roughness, and intradermal collagen density increase. Photomedicine and Laser Surgery, 32(2), 93–100. PubMed
